furosemide has been researched along with nystatin a1 in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nikulin, KG | 1 |
| Bennett, LL; Dagnino, L; Paterson, AR | 1 |
| Boulanger, Y; Gougoux, A; Noel, J; Tejedor, A; Vinay, P | 1 |
| Hus-Citharel, A; Morel, F | 1 |
| Brugnara, C; Canessa, M | 1 |
| Brezis, M; Epstein, FH; Rosen, S; Silva, P; Spokes, K | 1 |
| Borisov, IuA; Fedorovich, EE; Soboleva, OIu; Suglobova, ED | 1 |
| Lister, G | 1 |
| Garvin, JL; Hong, NJ; Ortiz, PA | 1 |
| Carretero, OA; Garvin, JL; Ren, Y; Wang, H; Yu, H | 1 |
2 review(s) available for furosemide and nystatin a1
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Metabolic responses to hypoxia.
Topics: Adaptation, Physiological; Age Factors; Animals; Animals, Newborn; Digoxin; Energy Metabolism; Furosemide; Growth; Humans; Hypoxia; Infant, Newborn; Nystatin; Ouabain; Oxygen Consumption; Potassium Channels; Rats; Seals, Earless; Sheep; Sodium-Potassium-Exchanging ATPase; Swine; Turtles | 1993 |
13 other study(ies) available for furosemide and nystatin a1
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
[Principles of current therapy of acute and chronic pneumonia].
Topics: Acute Disease; Aminophylline; Anti-Bacterial Agents; Blood Coagulation; Body Temperature; Chronic Disease; Erythromycin; Furosemide; Heparin; Humans; Nikethamide; Nystatin; Oleandomycin; Penicillins; Peptide Hydrolases; Physical Therapy Modalities; Plasma Substitutes; Pneumonia; Pneumonia, Staphylococcal; Streptomycin; Strophanthins; Sulfadimethoxine; Sulfanilamides; Tetracycline; Vitamins | 1975 |
Sodium-dependent nucleoside transport in mouse leukemia L1210 cells.
Topics: Adenosine; Animals; Biological Transport; Formycins; Furosemide; Leukemia L1210; Mice; Nucleosides; Nystatin; Sodium; Thioinosine; Tumor Cells, Cultured | 1991 |
Characterization and metabolism of canine proximal tubules, thick ascending limbs, and collecting ducts in suspension.
Topics: Adenosine Monophosphate; Adenosine Triphosphatases; Animals; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Dogs; Furosemide; Gluconeogenesis; Kidney Tubules; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Nephrons; Nystatin; Ouabain; Oxygen Consumption; Reference Values | 1988 |
Coupling of metabolic CO2 production to ion transport in isolated rat thick ascending limbs and collecting tubules.
Topics: Animals; Biological Transport, Active; Carbon Dioxide; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Chlorides; Furosemide; Glucose; In Vitro Techniques; Kidney Tubules; Kidney Tubules, Collecting; Lactates; Lactic Acid; Loop of Henle; Nystatin; Osmotic Pressure; Potassium; Rats; Sodium | 1986 |
The regulation of Na-K cotransport system and essential hypertension.
Topics: Biological Transport; Erythrocytes; Furosemide; Humans; Hypertension; Kinetics; Nystatin; Potassium; Sodium | 1985 |
Polyene toxicity in renal medulla: injury mediated by transport activity.
Topics: Amphotericin B; Animals; Biological Transport, Active; Cell Membrane Permeability; Furosemide; Glomerular Filtration Rate; Kidney Medulla; Loop of Henle; Nystatin; Ouabain; Oxygen Consumption; Polyenes; Rats; Sodium; Sodium-Potassium-Exchanging ATPase | 1984 |
[Na+ and K+ ion transport across the human erythrocyte membrane during the formation of nystatin channels under in-vitro conditions: the characteristics and an analysis of the processes].
Topics: Biological Transport, Active; Diffusion; Dose-Response Relationship, Drug; Erythrocyte Membrane; Furosemide; Humans; In Vitro Techniques; Nystatin; Ouabain; Potassium; Potassium Channels; Sodium; Sodium Channels; Sodium-Potassium-Exchanging ATPase; Time Factors | 1994 |
NO decreases thick ascending limb chloride absorption by reducing Na(+)-K(+)-2Cl(-) cotransporter activity.
Topics: Animals; Chlorides; Electric Conductivity; Furosemide; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Nystatin; Potassium; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sodium; Sodium Chloride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Sodium-Potassium-Exchanging ATPase; Spermine | 2001 |
Nystatin and valinomycin induce tubuloglomerular feedback.
Topics: Animals; Arterioles; Chloride Channels; Chlorides; Culture Techniques; Feedback, Physiological; Furosemide; Ion Transport; Ionophores; Kidney Glomerulus; Kidney Tubules, Distal; Nitrobenzoates; Nystatin; Potassium; Rabbits; Renal Circulation; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Valinomycin | 2001 |